 | • レポートコード：GIR-105X09522 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、注射可能ナノメディシンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。注射可能ナノメディシンの種類別市場規模（リポソーム、ミセル、ナノ結晶、高分子ナノ粒子、その他）、用途別市場規模（がん、中枢神経系疾患、心血管疾患、感染管理、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・注射可能ナノメディシンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Lupin、Pacira Pharmaceuticals、Celgene Pharmaceutical、Amgen、Janssen Biotech、Pfizer、Hoffmann-La Roche、Teva Pharmaceutical Industries、Bausch & Lomb ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：リポソーム、ミセル、ナノ結晶、高分子ナノ粒子、その他 ・用途別分析2016年-2026年：がん、中枢神経系疾患、心血管疾患、感染管理、その他 ・注射可能ナノメディシンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・注射可能ナノメディシンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・注射可能ナノメディシンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・注射可能ナノメディシンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・注射可能ナノメディシンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Injectable Nanomedicines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Injectable Nanomedicines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Injectable Nanomedicines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Injectable Nanomedicines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Liposomes
Micelles
Nanocrystals
Polymeric Nanoparticles
Other
Market segment by Application can be divided into
Cancer
Central Nervous System Disease
Cardiovascular Disease
Infection Control
Other
The key market players for global Injectable Nanomedicines market are listed below:
Merck
Lupin
Pacira Pharmaceuticals
Celgene Pharmaceutical
Amgen
Janssen Biotech
Pfizer
Hoffmann-La Roche
Teva Pharmaceutical Industries
Bausch & Lomb
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Injectable Nanomedicines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Injectable Nanomedicines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Liposomes
1.2.3 Micelles
1.2.4 Nanocrystals
1.2.5 Polymeric Nanoparticles
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Injectable Nanomedicines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Central Nervous System Disease
1.3.4 Cardiovascular Disease
1.3.5 Infection Control
1.3.6 Other
1.4 Global Injectable Nanomedicines Market Size & Forecast
1.4.1 Global Injectable Nanomedicines Sales in Value (2016-2026))
1.4.2 Global Injectable Nanomedicines Sales in Volume (2016-2026)
1.4.3 Global Injectable Nanomedicines Price by Type (2016-2026) & (USD/Kg)
1.5 Global Injectable Nanomedicines Production Capacity Analysis
1.5.1 Global Injectable Nanomedicines Total Production Capacity (2016-2026)
1.5.2 Global Injectable Nanomedicines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Injectable Nanomedicines Market Drivers
1.6.2 Injectable Nanomedicines Market Restraints
1.6.3 Injectable Nanomedicines Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Injectable Nanomedicines Product and Services
2.1.4 Merck Injectable Nanomedicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Lupin
2.2.1 Lupin Details
2.2.2 Lupin Major Business
2.2.3 Lupin Injectable Nanomedicines Product and Services
2.2.4 Lupin Injectable Nanomedicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pacira Pharmaceuticals
2.3.1 Pacira Pharmaceuticals Details
2.3.2 Pacira Pharmaceuticals Major Business
2.3.3 Pacira Pharmaceuticals Injectable Nanomedicines Product and Services
2.3.4 Pacira Pharmaceuticals Injectable Nanomedicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Celgene Pharmaceutical
2.4.1 Celgene Pharmaceutical Details
2.4.2 Celgene Pharmaceutical Major Business
2.4.3 Celgene Pharmaceutical Injectable Nanomedicines Product and Services
2.4.4 Celgene Pharmaceutical Injectable Nanomedicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Injectable Nanomedicines Product and Services
2.5.4 Amgen Injectable Nanomedicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Janssen Biotech
2.6.1 Janssen Biotech Details
2.6.2 Janssen Biotech Major Business
2.6.3 Janssen Biotech Injectable Nanomedicines Product and Services
2.6.4 Janssen Biotech Injectable Nanomedicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Injectable Nanomedicines Product and Services
2.7.4 Pfizer Injectable Nanomedicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Hoffmann-La Roche
2.8.1 Hoffmann-La Roche Details
2.8.2 Hoffmann-La Roche Major Business
2.8.3 Hoffmann-La Roche Injectable Nanomedicines Product and Services
2.8.4 Hoffmann-La Roche Injectable Nanomedicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Teva Pharmaceutical Industries
2.9.1 Teva Pharmaceutical Industries Details
2.9.2 Teva Pharmaceutical Industries Major Business
2.9.3 Teva Pharmaceutical Industries Injectable Nanomedicines Product and Services
2.9.4 Teva Pharmaceutical Industries Injectable Nanomedicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Bausch & Lomb
2.10.1 Bausch & Lomb Details
2.10.2 Bausch & Lomb Major Business
2.10.3 Bausch & Lomb Injectable Nanomedicines Product and Services
2.10.4 Bausch & Lomb Injectable Nanomedicines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Injectable Nanomedicines Sales by Manufacturer
3.1 Global Injectable Nanomedicines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Injectable Nanomedicines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Injectable Nanomedicines
3.4 Market Concentration Rate
3.4.1 Top 3 Injectable Nanomedicines Manufacturer Market Share
3.4.2 Top 6 Injectable Nanomedicines Manufacturer Market Share
3.5 Global Injectable Nanomedicines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Injectable Nanomedicines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Injectable Nanomedicines Market Size by Region
4.1.1 Global Injectable Nanomedicines Sales in Volume by Region (2016-2026)
4.1.2 Global Injectable Nanomedicines Revenue by Region (2016-2026)
4.2 North America Injectable Nanomedicines Revenue (2016-2026)
4.3 Europe Injectable Nanomedicines Revenue (2016-2026)
4.4 Asia-Pacific Injectable Nanomedicines Revenue (2016-2026)
4.5 South America Injectable Nanomedicines Revenue (2016-2026)
4.6 Middle East and Africa Injectable Nanomedicines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Injectable Nanomedicines Sales in Volume by Type (2016-2026)
5.2 Global Injectable Nanomedicines Revenue by Type (2016-2026)
5.3 Global Injectable Nanomedicines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Injectable Nanomedicines Sales in Volume by Application (2016-2026)
6.2 Global Injectable Nanomedicines Revenue by Application (2016-2026)
6.3 Global Injectable Nanomedicines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Injectable Nanomedicines Sales by Type (2016-2026)
7.2 North America Injectable Nanomedicines Sales by Application (2016-2026)
7.3 North America Injectable Nanomedicines Market Size by Country
7.3.1 North America Injectable Nanomedicines Sales in Volume by Country (2016-2026)
7.3.2 North America Injectable Nanomedicines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Injectable Nanomedicines Sales by Type (2016-2026)
8.2 Europe Injectable Nanomedicines Sales by Application (2016-2026)
8.3 Europe Injectable Nanomedicines Market Size by Country
8.3.1 Europe Injectable Nanomedicines Sales in Volume by Country (2016-2026)
8.3.2 Europe Injectable Nanomedicines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Injectable Nanomedicines Sales by Type (2016-2026)
9.2 Asia-Pacific Injectable Nanomedicines Sales by Application (2016-2026)
9.3 Asia-Pacific Injectable Nanomedicines Market Size by Region
9.3.1 Asia-Pacific Injectable Nanomedicines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Injectable Nanomedicines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Injectable Nanomedicines Sales by Type (2016-2026)
10.2 South America Injectable Nanomedicines Sales by Application (2016-2026)
10.3 South America Injectable Nanomedicines Market Size by Country
10.3.1 South America Injectable Nanomedicines Sales in Volume by Country (2016-2026)
10.3.2 South America Injectable Nanomedicines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Injectable Nanomedicines Sales by Type (2016-2026)
11.2 Middle East & Africa Injectable Nanomedicines Sales by Application (2016-2026)
11.3 Middle East & Africa Injectable Nanomedicines Market Size by Country
11.3.1 Middle East & Africa Injectable Nanomedicines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Injectable Nanomedicines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Injectable Nanomedicines Typical Distributors
12.3 Injectable Nanomedicines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Injectable Nanomedicines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Injectable Nanomedicines Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Injectable Nanomedicines Product and Services
Table 6. Merck Injectable Nanomedicines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Lupin Basic Information, Manufacturing Base and Competitors
Table 8. Lupin Major Business
Table 9. Lupin Injectable Nanomedicines Product and Services
Table 10. Lupin Injectable Nanomedicines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pacira Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Pacira Pharmaceuticals Major Business
Table 13. Pacira Pharmaceuticals Injectable Nanomedicines Product and Services
Table 14. Pacira Pharmaceuticals Injectable Nanomedicines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Celgene Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Celgene Pharmaceutical Major Business
Table 17. Celgene Pharmaceutical Injectable Nanomedicines Product and Services
Table 18. Celgene Pharmaceutical Injectable Nanomedicines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Amgen Basic Information, Manufacturing Base and Competitors
Table 20. Amgen Major Business
Table 21. Amgen Injectable Nanomedicines Product and Services
Table 22. Amgen Injectable Nanomedicines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table 24. Janssen Biotech Major Business
Table 25. Janssen Biotech Injectable Nanomedicines Product and Services
Table 26. Janssen Biotech Injectable Nanomedicines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Major Business
Table 29. Pfizer Injectable Nanomedicines Product and Services
Table 30. Pfizer Injectable Nanomedicines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 32. Hoffmann-La Roche Major Business
Table 33. Hoffmann-La Roche Injectable Nanomedicines Product and Services
Table 34. Hoffmann-La Roche Injectable Nanomedicines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 36. Teva Pharmaceutical Industries Major Business
Table 37. Teva Pharmaceutical Industries Injectable Nanomedicines Product and Services
Table 38. Teva Pharmaceutical Industries Injectable Nanomedicines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Bausch & Lomb Basic Information, Manufacturing Base and Competitors
Table 40. Bausch & Lomb Major Business
Table 41. Bausch & Lomb Injectable Nanomedicines Product and Services
Table 42. Bausch & Lomb Injectable Nanomedicines Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Injectable Nanomedicines Sales by Manufacturer (2019-2021e) & (MT)
Table 44. Global Injectable Nanomedicines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Injectable Nanomedicines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Injectable Nanomedicines Production Capacity by Company, (MT): 2020 VS 2021
Table 47. Head Office and Injectable Nanomedicines Production Site of Key Manufacturer
Table 48. Global Injectable Nanomedicines Sales by Region (2016-2021e) & (MT)
Table 49. Global Injectable Nanomedicines Sales by Region (2021-2026) & (MT)
Table 50. Global Injectable Nanomedicines Revenue by Region (2016-2021e) & (USD Million)
Table 51. Global Injectable Nanomedicines Revenue by Region (2021-2026) & (USD Million)
Table 52. Global Injectable Nanomedicines Sales by Type (2016-2021e) & (MT)
Table 53. Global Injectable Nanomedicines Sales by Type (2021-2026) & (MT)
Table 54. Global Injectable Nanomedicines Revenue by Type (2016-2021e) & (USD Million)
Table 55. Global Injectable Nanomedicines Revenue by Type (2021-2026) & (USD Million)
Table 56. Global Injectable Nanomedicines Price by Type (2016-2021e) & (USD/Kg)
Table 57. Global Injectable Nanomedicines Price by Type (2021-2026) & (USD/Kg)
Table 58. Global Injectable Nanomedicines Sales by Application (2016-2021e) & (MT)
Table 59. Global Injectable Nanomedicines Sales by Application (2021-2026) & (MT)
Table 60. Global Injectable Nanomedicines Revenue by Application (2016-2021e) & (USD Million)
Table 61. Global Injectable Nanomedicines Revenue by Application (2021-2026) & (USD Million)
Table 62. Global Injectable Nanomedicines Price by Application (2016-2021e) & (USD/Kg)
Table 63. Global Injectable Nanomedicines Price by Application (2021-2026) & (USD/Kg)
Table 64. North America Injectable Nanomedicines Sales by Country (2016-2021e) & (MT)
Table 65. North America Injectable Nanomedicines Sales by Country (2021-2026) & (MT)
Table 66. North America Injectable Nanomedicines Revenue by Country (2016-2021e) & (USD Million)
Table 67. North America Injectable Nanomedicines Revenue by Country (2021-2026) & (USD Million)
Table 68. North America Injectable Nanomedicines Sales by Type (2016-2021e) & (MT)
Table 69. North America Injectable Nanomedicines Sales by Type (2021-2026) & (MT)
Table 70. North America Injectable Nanomedicines Sales by Application (2016-2021e) & (MT)
Table 71. North America Injectable Nanomedicines Sales by Application (2021-2026) & (MT)
Table 72. Europe Injectable Nanomedicines Sales by Country (2016-2021e) & (MT)
Table 73. Europe Injectable Nanomedicines Sales by Country (2021-2026) & (MT)
Table 74. Europe Injectable Nanomedicines Revenue by Country (2016-2021e) & (USD Million)
Table 75. Europe Injectable Nanomedicines Revenue by Country (2021-2026) & (USD Million)
Table 76. Europe Injectable Nanomedicines Sales by Type (2016-2021e) & (MT)
Table 77. Europe Injectable Nanomedicines Sales by Type (2021-2026) & (MT)
Table 78. Europe Injectable Nanomedicines Sales by Application (2016-2021e) & (MT)
Table 79. Europe Injectable Nanomedicines Sales by Application (2021-2026) & (MT)
Table 80. Asia-Pacific Injectable Nanomedicines Sales by Region (2016-2021e) & (MT)
Table 81. Asia-Pacific Injectable Nanomedicines Sales by Region (2021-2026) & (MT)
Table 82. Asia-Pacific Injectable Nanomedicines Revenue by Region (2016-2021e) & (USD Million)
Table 83. Asia-Pacific Injectable Nanomedicines Revenue by Region (2021-2026) & (USD Million)
Table 84. Asia-Pacific Injectable Nanomedicines Sales by Type (2016-2021e) & (MT)
Table 85. Asia-Pacific Injectable Nanomedicines Sales by Type (2021-2026) & (MT)
Table 86. Asia-Pacific Injectable Nanomedicines Sales by Application (2016-2021e) & (MT)
Table 87. Asia-Pacific Injectable Nanomedicines Sales by Application (2021-2026) & (MT)
Table 88. South America Injectable Nanomedicines Sales by Country (2016-2021e) & (MT)
Table 89. South America Injectable Nanomedicines Sales by Country (2021-2026) & (MT)
Table 90. South America Injectable Nanomedicines Revenue by Country (2016-2021e) & (USD Million)
Table 91. South America Injectable Nanomedicines Revenue by Country (2021-2026) & (USD Million)
Table 92. South America Injectable Nanomedicines Sales by Type (2016-2021e) & (MT)
Table 93. South America Injectable Nanomedicines Sales by Type (2021-2026) & (MT)
Table 94. South America Injectable Nanomedicines Sales by Application (2016-2021e) & (MT)
Table 95. South America Injectable Nanomedicines Sales by Application (2021-2026) & (MT)
Table 96. Middle East & Africa Injectable Nanomedicines Sales by Country (2016-2021e) & (MT)
Table 97. Middle East & Africa Injectable Nanomedicines Sales by Country (2021-2026) & (MT)
Table 98. Middle East & Africa Injectable Nanomedicines Revenue by Country (2016-2021e) & (USD Million)
Table 99. Middle East & Africa Injectable Nanomedicines Revenue by Country (2021-2026) & (USD Million)
Table 100. Middle East & Africa Injectable Nanomedicines Sales by Type (2016-2021e) & (MT)
Table 101. Middle East & Africa Injectable Nanomedicines Sales by Type (2021-2026) & (MT)
Table 102. Middle East & Africa Injectable Nanomedicines Sales by Application (2016-2021e) & (MT)
Table 103. Middle East & Africa Injectable Nanomedicines Sales by Application (2021-2026) & (MT)
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Injectable Nanomedicines Typical Distributors
Table 107. Injectable Nanomedicines Typical Customers
List of Figures
Figure 1. Injectable Nanomedicines Picture
Figure 2. Global Injectable Nanomedicines Sales Market Share by Type in 2020
Figure 3. Liposomes
Figure 4. Micelles
Figure 5. Nanocrystals
Figure 6. Polymeric Nanoparticles
Figure 7. Other
Figure 8. Global Injectable Nanomedicines Sales Market Share by Application in 2020
Figure 9. Cancer
Figure 10. Central Nervous System Disease
Figure 11. Cardiovascular Disease
Figure 12. Infection Control
Figure 13. Other
Figure 14. Global Injectable Nanomedicines Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 15. Global Injectable Nanomedicines Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. United States Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Canada Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Mexico Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Germany Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. France Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. United Kingdom Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Russia Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Italy Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. China Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Japan Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Korea Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. India Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Southeast Asia Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Australia Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Brazil Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Egypt Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Saudi Arabia Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. South Africa Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Turkey Injectable Nanomedicines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Global Injectable Nanomedicines Sales (2016-2026) & (MT)
Figure 36. Global Injectable Nanomedicines Production Capacity (2016-2026) & (MT)
Figure 37. Global Injectable Nanomedicines Production Capacity by Geographic Region: 2020 VS 2021
Figure 38. Injectable Nanomedicines Market Drivers
Figure 39. Injectable Nanomedicines Market Restraints
Figure 40. Injectable Nanomedicines Market Trends
Figure 41. Global Injectable Nanomedicines Sales Market Share by Manufacturer in 2020
Figure 42. Global Injectable Nanomedicines Revenue Market Share by Manufacturer in 2020
Figure 43. Injectable Nanomedicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 44. Top 3 Injectable Nanomedicines Manufacturer (Revenue) Market Share in 2020
Figure 45. Top 6 Injectable Nanomedicines Manufacturer (Revenue) Market Share in 2020
Figure 46. Global Injectable Nanomedicines Sales Market Share by Region (2016-2026)
Figure 47. Global Injectable Nanomedicines Revenue Market Share by Region (2016-2026)
Figure 48. North America Injectable Nanomedicines Revenue (2016-2026) & (USD Million)
Figure 49. Europe Injectable Nanomedicines Revenue (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Injectable Nanomedicines Revenue (2016-2026) & (USD Million)
Figure 51. South America Injectable Nanomedicines Revenue (2016-2026) & (USD Million)
Figure 52. Middle East & Africa Injectable Nanomedicines Revenue (2016-2026) & (USD Million)
Figure 53. Global Injectable Nanomedicines Sales Market Share by Type (2016-2026)
Figure 54. Global Injectable Nanomedicines Revenue Market Share by Type (2016-2026)
Figure 55. Global Injectable Nanomedicines Price by Type (2016-2026) & (USD/Kg)
Figure 56. Global Injectable Nanomedicines Sales Market Share by Application (2016-2026)
Figure 57. Global Injectable Nanomedicines Revenue Market Share by Application (2016-2026)
Figure 58. Global Injectable Nanomedicines Price by Application (2016-2026) & (USD/Kg)
Figure 59. North America Injectable Nanomedicines Sales Market Share by Country (2016-2026)
Figure 60. North America Injectable Nanomedicines Revenue Market Share by Country (2016-2026)
Figure 61. North America Injectable Nanomedicines Sales Market Share by Type (2016-2026)
Figure 62. North America Injectable Nanomedicines Sales Market Share by Application (2016-2026)
Figure 63. Europe Injectable Nanomedicines Sales Market Share by Country (2016-2026)
Figure 64. Europe Injectable Nanomedicines Revenue Market Share by Country (2016-2026)
Figure 65. Europe Injectable Nanomedicines Sales Market Share by Type (2016-2026)
Figure 66. Europe Injectable Nanomedicines Sales Market Share by Application (2016-2026)
Figure 67. Asia-Pacific Injectable Nanomedicines Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Injectable Nanomedicines Revenue Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Injectable Nanomedicines Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Injectable Nanomedicines Sales Market Share by Application (2016-2026)
Figure 71. South America Injectable Nanomedicines Sales Market Share by Country (2016-2026)
Figure 72. South America Injectable Nanomedicines Revenue Market Share by Country (2016-2026)
Figure 73. South America Injectable Nanomedicines Sales Market Share by Type (2016-2026)
Figure 74. South America Injectable Nanomedicines Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Injectable Nanomedicines Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Injectable Nanomedicines Revenue Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Injectable Nanomedicines Sales Market Share by Type (2016-2026)
Figure 78. Middle East & Africa Injectable Nanomedicines Sales Market Share by Application (2016-2026)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の注射可能リン酸カリウム（リン酸カリウム注射）市場 2021：企業別、地域別、種類・用途別 The Injectable Potassium Phosphate (Potassium Phosphate Injection) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, …- 世界の注射可能生殖ホルモン市場 2021：企業別、地域別、種類・用途別 The Injectable Reproductive Hormone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界の美容整形用注射剤市場 2021：企業別、地域別、種類・用途別 The Injectable for Cosmetic Surgery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界のモノクローナル抗体滅菌注射薬市場 2021：企業別、地域別、種類・用途別 The Monoclonal Antibodies Sterile Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- 世界の動物用注射デバイス市場 2021：企業別、地域別、種類・用途別 The Veterinary Injectable Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…